Bicycle therapeutics CTO sells shares worth over 21k
BCYC Stock | USD 10.97 0.06 0.54% |
About 62% of Bicycle Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Bicycle Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Bicycle Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Bicycle Therapeutics stock news signals to limit their universe of possible portfolio assets.
Bicycle |
Bicycle therapeutics CTO sells shares worth over 21k
Read at investing.com
![]() |
Bicycle Therapeutics Fundamental Analysis
We analyze Bicycle Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bicycle Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bicycle Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash And Equivalents
Cash And Equivalents Comparative Analysis
Bicycle Therapeutics is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Bicycle Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bicycle Therapeutics stock to make a market-neutral strategy. Peer analysis of Bicycle Therapeutics could also be used in its relative valuation, which is a method of valuing Bicycle Therapeutics by comparing valuation metrics with similar companies.
Peers
Bicycle Therapeutics Related Equities
INBX | Inhibrx | 5.16 | ||||
CCCC | C4 Therapeutics | 4.23 | ||||
ANAB | AnaptysBio | 2.56 | ||||
ORIC | Oric Pharmaceuticals | 2.42 | ||||
MGTX | MeiraGTx Holdings | 2.15 | ||||
MRUS | Merus BV | 1.88 | ||||
IDYA | Ideaya Biosciences | 1.63 | ||||
IGMS | IGM Biosciences | 1.49 | ||||
TNYA | Tenaya Therapeutics | 1.00 | ||||
GLUE | Monte Rosa | 0.92 | ||||
KROS | Keros Therapeutics | 0.64 | ||||
ACRV | Acrivon Therapeutics, | 0.56 | ||||
ADAG | Adagene | 0.99 | ||||
CGEM | Cullinan Oncology | 1.39 | ||||
STOK | Stoke Therapeutics | 1.75 | ||||
ANEB | Anebulo Pharmaceuticals | 3.33 | ||||
SEER | Seer | 4.55 | ||||
MLYS | Mineralys Therapeutics, | 8.23 |
Complementary Tools for Bicycle Stock analysis
When running Bicycle Therapeutics' price analysis, check to measure Bicycle Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bicycle Therapeutics is operating at the current time. Most of Bicycle Therapeutics' value examination focuses on studying past and present price action to predict the probability of Bicycle Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bicycle Therapeutics' price. Additionally, you may evaluate how the addition of Bicycle Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |